Assist. Prof. Dr. Haoqiang Zhao, Beijing University of Chinese Medicine, China
Haoqiang Zhao is an Assistant Professor at the School of Chinese Materia Medica, Beijing University of Chinese Medicine, China. His research focuses on the chiral assembly study based on active ingredients from traditional Chinese medicine. He has published 16 SCI papers and has been the principal investigator for several national-level projects. Zhao has participated in international conferences and is recognized for his contributions to organic chemistry and material science. His work has been cited over 550 times, and his research has been highlighted by prominent journals like Wiley Chem and Synfacts. š±š¬š
Professional Profile:
Scopus
Summary of Suitability
Haoqiang Zhaoās innovative research, leadership in national and international projects, and interdisciplinary approach to traditional and modern medicine make him an ideal candidate for the Best Researcher Award. His work has had a profound impact on both theoretical and practical applications, bridging the gap between traditional Chinese medicine and contemporary scientific advancements. With his extensive research contributions and academic excellence, Zhao is highly deserving of this prestigious recognition. š
Education
- B.A. in Applied Chemistry (2010-2014)
Qingdao University of Science & Technology, China šš§Ŗ
- Ph.D. in Organic Chemistry (2015-2021)
Renmin University of China, Beijing, China šš¬
- Joint Ph.D. in Organic Chemistry (2019-2021)
University of Pennsylvania, USA šŗšøš¬
Professional Development
Haoqiang Zhao has gained diverse research experience, including his joint Ph.D. program at the University of Pennsylvania under the mentorship of Patrick J. Walsh. His primary focus is on chiral assembly and its applications in traditional Chinese medicine, contributing significantly to organic chemistry and material science.
Zhao has led national research projects and collaborated internationally. He has also presented his research at global conferences and has been an invited speaker at various academic gatherings. His work has contributed to both theoretical and practical applications in chemistry and medicinal science. ššØāš¬š
Research Focus
Haoqiang Zhao’s research focuses on chiral assembly, particularly through the study of active ingredients in traditional Chinese medicine. By exploring the unique properties of these chiral assemblies, his work aims to uncover novel biomedical applications.
Zhao also investigates organic chemistry, synthetic methods, and the development of novel materials with therapeutic potential. His interdisciplinary approach integrates chemistry, material science, and medicine to develop innovative solutions for healthcare, including wound healing and antibacterial applications. His research bridges the gap between traditional medicine and modern scientific advancements. š§¬šš¬
Awards and Honors
- Presided over two National Natural Science Foundation of China Youth Fund projects ššØš³
- Contributed to projects funded by the National Science Foundation (US) š”š
- Published 16 SCI papers with over 550 citations ššØāš¬
- Highlighted in reports by Wiley Chem and Synfacts š°ā
- Invited to present at international conferences (e.g., Philadelphia Organic Chemistry Club) š¤š
Publication Top Notes:
-
š¬ Borane-Catalyzed Tandem Cyclization/Hydrosilylation Towards Enantio- and Diastereoselective Construction of trans-2,3-Disubstituted-1,2,3,4-Tetrahydroquinoxalines (Cited by: 14, Year: 2023)
-
š” Palladium-Catalyzed Benzylic C(sp3)āH Carbonylative Arylation with Aryl Bromides (Cited by: 2, Year: 2023)
-
š„ Rhodium(III-Catalyzed C8-Selective CāH Alkenylation and Alkylation of 1, 2, 3, 4-Tetrahydroquinolines with Styrenes and Allylic Alcohols (Cited by: 4, Year: 2023)
-
šæ Thermodynamics driving phytochemical self-assembly morphological change and efficacy enhancement originated from single and co-decoction of traditional Chinese medicine (Cited by: 25, Year: 2022)
-
š§Ŗ Rhodium(i)-catalyzed directed trideuteromethylation of (hetero)arene C-H bonds with CD3CO2D (Cited by: 4, Year: 2022